INSIGHTS ON DRUG DEVELOPMENT

• Thermofluor Screening For Injectable Protein Formulations

  The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.

• Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems

  For years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.

• Evolving Gene Editing For Rare Disease Drug Development

  Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.

• Selecting A CDMO For Custom Activated PEGs

  Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.

• ADC Manufacturing: Practices, Challenges, And The Road Ahead

  6/15/2026

  ADCs are advancing quickly, but manufacturing complexity is rising just as fast. Key challenges in scale-up, regulation, and costs are reshaping how the next generation of therapies will be delivered.

• The Delicate Dance: When Phase-Appropriate Decisions Carry More Risk

  9/23/2026

   Early drug development demands speed, but some decisions carry long-term consequences. Learn which process and analytical choices require teams to look beyond the next milestone.

• IP Considerations In Drug Development For Biotech Companies

  4/20/2026

  Integrate a strategic intellectual property approach early in drug development to streamline research, uncover opportunities, and maximize the return on your investment.

• The 5 Ws Of A Human Factors Strategy

  3/31/2025

  A human factors strategy ensures medical products are safe, effective, and compliant by integrating user-focused design early, reducing risks, and optimizing regulatory approval processes.

• Drug Development Plan Explained: DPP Templates And Examples

  7/27/2026

  Only 6.7% of Phase 1 drugs reach approval. A well-structured Drug Development Plan (DDP) can meaningfully improve your odds — learn exactly how to build one.